A resolution expressing support for the designation of September 2025 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.

The Senate formally expressed support for September 2025 as Sickle Cell Disease Awareness Month, a designation aimed at educating communities about a blood disorder that affects an estimated 100,000 Americans — disproportionately Black and African American individuals — and can significantly shorten life expectancy. The resolution — agreed to by the Senate — encourages public programs to raise awareness of the sickle cell trait, early detection, and recently FDA-approved gene therapies that have shown potential for a cure. It is a symbolic designation and does not appropriate funds or mandate programs.